Given that dyslipidemia is an independent risk factor for DPN, APOE variants likely modulate neuropathy susceptibility through lipid homeostasis mechanisms (31) (detailed mechanistic pathways are illustrated in Figure 1 and discussed below). Here, APOE is linked to metabolic syndrome.